Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspective
- 1 September 2020
- journal article
- review article
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 14 (5) , 971-978
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Glucocorticoid‐induced hyperglycemia (糖皮质激素诱导的高血糖)Journal of Diabetes, 2013
- Activation and Regulation of Systemic Inflammation in ARDSChest, 2009
- SARS: Systematic Review of Treatment EffectsPLOS Medicine, 2006
- Treatment of Severe Acute Respiratory Syndrome With GlucosteroidsChest, 2006
- Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old DrugsNew England Journal of Medicine, 2005
- Osteonecrosis of Hip and Knee in Patients with Severe Acute Respiratory Syndrome Treated with SteroidsRadiology, 2005
- Hyperglycemia in Patients Administered Dexamethasone for CraniotomyAnesthesia & Analgesia, 2005
- Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR ChinaJournal of Medical Microbiology, 2003
- Acute Respiratory Distress Syndrome in Critically Ill Patients With Severe Acute Respiratory SyndromeJAMA, 2003
- The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated InflammationNew England Journal of Medicine, 1995